Adipose tissue as an endocrine and paracrine organ

International Journal of Obesity

Volumn 22, Issue 12, 1998, Pages 1145-1158

  Mohamed Ali, V ^a   Pinkney, J H ^b   Coppack, S W ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Adipose tissue; Catecholamines; IL 6; Insulin; Leptin; TNF

Indexed keywords

ADENOHYPOPHYSIS HORMONE; CATECHOLAMINE DERIVATIVE; COMPLEMENT COMPONENT C3; CYTOKINE; FATTY ACID; GLUCOCORTICOID; INSULIN; INTERLEUKIN 6; LEPTIN; LIPID; SEX HORMONE; STEROID HORMONE; TUMOR NECROSIS FACTOR ALPHA;

ADENOHYPOPHYSIS; ADIPOCYTE; ADIPOSE TISSUE; COMPLEMENT SYSTEM; CYTOKINE PRODUCTION; ENDOCRINE GLAND; ENERGY METABOLISM; HOMEOSTASIS; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INFECTION; LIPID METABOLISM; NEUROENDOCRINE SYSTEM; NONHUMAN; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REPRODUCTION; REVIEW; SEXUAL MATURATION; STARVATION; STEROIDOGENESIS; STRESS; SYMPATHETIC TONE;

EID: 0031736064     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0800770     Document Type: Review

References (152)

1. Siiteri PK. Adipose tissue as a source of hormones. Am J Clin Nutr 1987; 45 (Suppl 1): 277-282.
2. Caro JF, Sinha MK, Kolaczynski JW, Zhang PL, Considine RV. Leptin: the tale of an obesity gene. Diabetes 1996; 45: 1455-1462.
3. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993; 259: 87-91.
4. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, Klein S, Coppack SW. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α, in vivo. J Clin Endocrinol Metab 1997; 82: 4196-4200.
5. Frayn KN. Role of non-esterified fatty acids in the metabolic changes of obesity. Int J Obesity 1996; 20 (Suppl 4): 7-10.
6. Cianflone K, Sniderman AD, Summers LKM, Fielding BA, Frayn KN. Post prandial generation of acylation stimulating protein by human adipose tissue in vivo. Proc Nutr Soc 1997; 56: (Abstract) 190.
7. Coppack SW, Yost TJ, Fisher RM, Eckel RH, Miles JM. Periprandial systemic and regional lipase activity in normal man. Am J Physiol 1996; 270: E718-E722.
8. Beisiegel U, Heeren J. Lipoprotein lipase (EC 3.1.1.34) targeting of lipoproteins to receptors. Proc Nutr Soc 1997; 56: 731-773.
9. Ailhaud G, Grimaldi P, Negrel R. Cellular and molecular aspects of adipose tissue development. Annu Rev Nutr 1992; 12: 207-233.
10. Juhan-Vague I, Alessi MC. PAI-1, obesity, insulin resistance and risk of cardiovascular events. Thromb Haemost 1997; 78: 656-660.
11. Zorad S, Fickova M, Zelezna B, Macho I, Kraj G. The role of angiotensin II and its receptors in regulation of adipose tissue metabolism and cellularity. Gen Physiol Biophys 1995; 14: 383-391.
12. Chen NX, Hausman GJ, Wright JT. Influence of thyroxine in vivo on preadipocyte development and insulin-like growth factor-I and IGF binding protein secretion in fetal stromal vascular cell cultures. Obes Res 1996; 4: 357-366.
13. Trayhurn P. New insights into the development of obesity: obese genes and the leptin system. Proc Nutr Soc 1996; 55: 783-791.
14. Mounzih K, Lu R, Chehab FF. Leptin treatment rescues the sterility of genetically obese ob/ob males. Endocrinology 1997; 138: 1190-1193.
15. Ahima RS, Dushay J, Flier SN, Prabakaran D, Flier JS. Leptin accelerates the onset of puberty in normal female mice. J Clin Invest 1997; 99: 391-395.
16. Malmstrom R, Taskinen MR, Karonen SL, Yki-Jarvinen H. Insulin increases plasma leptin concentrations in normal subjects and patients with NIDDM. Diabetologia 1996; 39: 993-996.
17. Wabitsch M, Jensen PB, Blum WF, Christoffersen CT, Englaro P, Heinze E, Rascher W, Teller W, Tornqvist H, Hauner H. Insulin and cortisol promote leptin production in cultured human fat cells. Diabetes 1996; 45: 1435-1438.
18. Hardie LJ, Rayner DV, Holmes S, Trayhurn P. Circulating leptin levels are modulated by fasting, cold exposure and insulin administration in lean but not Zucker (fa/fa) rats as measured by ELISA. Biochem Biophys Res Commun 1996; 223: 660-665.
19. Sarraf P, Frederich RC, Turner EM, Ma G, Jaskowiak NT, Rivet DJ 3rd, Flier JS, Lowell BB, Fraker DL, Alexander HR. Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia. J Exp Med 1997; 185: 171-175.
20. Considine RV, Nyce MR, Kolaczynski JW, Zhang PL, Ohannesian JP, Moore JH Jr, Fox JW, Caro JF. Dexamethasone stimulates leptin release from human adipocytes: unexpected inhibition by insulin. J Cell Biochem 1997; 65: 254-258.
21. Fain JN, Coronel EC, Beauchamp MJ, Bahouth SW. Expression of leptin and beta 3-adrenergic receptors in rat adipose tissue in altered thyroid states. Biochem J 1997; 322: 145-150.
22. Escobar-Morreale HF, Escobar-del-Rey F, Morreale-de-Escobar G. Thyroid hormones influence serum leptin concentrations in the rat. Endocrinology 1997; 138: 4485-4488.
23. Pinkney JH, Goodrick SJ, Katz J, Johnson AB, Lightman SL, Coppack SW, Mohamed-Ali V. Leptin and the pituitary thyroid axis: A comparative study in lean, obese, hypothyroid and hyperthyroid subjects. Clin Endocrinol 1998; (in press).
24. Diamond FB Jr, Eichler DC, Duckett G, Jorgensen EV, Shulman D, Root AW. Demonstration of a leptin binding factor in human serum. Biochem Biophys Res Commun 1997; 233: 818-822.
25. Houseknecht KL, Mantzoros CS, Kuliawat R, Hadro E, Flier JS, Kahn BB. Evidence for leptin binding to proteins in serum of rodents and humans: modulation with obesity. Diabetes 1996; 45: 1638-1643.
26. Tartaglia LA. The leptin receptor. J Biol Chem 1997; 272: 6093-6096.
27. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards GJ, Campfield LA, Clark FT, Deeds J, Muir C, Sanker S, Moriarty A, Moore KJ, Smutko JS, Mays GG, Woolf EA, Monroe CA, Tepper RI. Identification and expression cloning of a leptin receptor, OB-R. Cell 1995; 83: 1263-1271.
28. Wang Y, Kuropatwinski KK, White DW, Hawley TS, Hawley RG, Tartaglia LA, Baumann H. Leptin receptor action in hepatic cells. J Biol Chem 1997; 272: 16216-16223.
29. Berti L, Kellerer M, Capp E, Haring HU. Leptin stimulates glucose transport and glycogen synthesis in C2C12 myotubes: evidence for a P13-kinase mediated effect. Diahetologia 1997; 40: 606-609.
30. Muller G, Ertl J, Gerl M, Preibisch G. Leptin impairs metabolic actions of insulin in isolated rat adipocytes. J Biol Chem 1997; 272: 10585-10593.
31. Bai Y, Zhang S, Kim KS, Lee JK, Kim KH. Obese gene expression alters the ability of 305A preadipocytes to respond to lipogenic hormones. J Biol Chem 1996; 271: 13939-13942.
32. Swinburn BA, Nyomba BL, Saad MF, Zurlo F, Raz I, Knowler WC, Lillioja S, Bogardus C, Ravussin E. Insulin resistance associated with lower rates of weight gain in Pima Indians. J Clin Invest 1991; 88: 168-173.
33. Ravussin E, Pratley RE, Maffei M, Wang H, Friedman JM, Bennett PH, Bogardus C. Relatively low plasma leptin concentrations precede weight gain in Pima Indians. Nat Med 1997; 3: 238-240.
34. Castell JV, Gomez-Lechon MJ, David M, Andus T, Geiger T, Trullenque R, Fabra R, Heinrich PC. Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS-Lett 1989; 242: 237-239.
35. Grunfeld C, Feingold KR. The metabolic effects of tumor necrosis factor and other cytokines. Biotherapy 1991; 3: 143-158.
36. Stouthard JM, Oude-Elferink RP, Sauerwein HP. Onterleukin-6 enhances glucose transport in 3T3-L1 adipocytes. Biochem Biophys Res Commun 1996; 220: 241-245.
37. Wang CN, O'Brien L, Brindley DN. Effects of cell-permeable ceramides and tumor necrosis factor-α on insulin signaling and glucose uptake in 3T3-L1 adipocytes. Diabetes 1998; 47: 24-31.
38. Hauner H, Petruschke T, Russ M, Rohrig K, Eckel J. Effects of tumour necrosis factor alpha (TNF-α) on glucose transport and lipid metabolism of newly-differentiated human fat cells in cell culture. Diabetologia 1995; 38: 764-771.
39. Ritchie DG. Interleukin 6 stimulates hepatic glucose release from prelabeled glycogen pools. Am J Physiol 1990; 258: E57-E64.
40. Stouthard JM, Romijn JA, Van-der-Poll T, Endert E, Klein S, Bakker PJ, Veenhof CH, Sauerwein HP. Endocrinologic and metabolic effects of interleukin-6 in humans. Am J Physiol 1995; 268: E813-E819.
41. Grunfeld C, Feingold KR. Regulation of lipid metabolism by cytokines during host defense. Nutrition 1996; 12: S24-S26.
42. Shimizu H, Sato N, Yanaka Y, Ohtani K, Fukatsu A, Mori M. Interleukin-6 stimulates insulin secretion in HIT-T 15 cells. Horm Metab Res 1995; 27: 37-38.
43. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 1995; 95: 2111-2119.
44. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995; 95: 2409-2415.
45. Purohit A, Ghilchik MW, Duncan L, Wang DY, Singh A, Walker MM, Reed MJ. Aromatase activity and interleukin-6 production by normal and malignant breast tissues. J Clin Endocrinol Metab 1995; 80: 3052-3058.
46. McCarthy PL. Down-regulation of cytokine action. Baillieres Clin Haematol 1994; 7: 153-177.
47. Mohamed-Ali V, Bulmer K, Coppack SW, Pinkney JH. β-adrenergic regulation of proinflammatory cytokines in humans in-vivo. J Endocrinol 1998; 156: (Abstract) 149.
48. Aderka D, Engelmann H, Maor Y, Brakebusch C, Wallach D. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med 1992; 175: 323-329.
49. Grell M. Tumor necrosis factor (TNF) receptors in cellular signaling of soluble and membrane-expressed TNF. J Inflamm 1995 1996; 47: 8-17.
50. Mohamed-Ali V, Bulmer K, Goodrick SJ, Coppack SW, Yudkin JS. Adipose derived interleukin-6, tumor necrosis factor-α and their soluble receptors. Endocrinology 1998; Accepted for oral presentation at the The Endocrine Society (Abstract).
51. Van-Zee KJ, Kohno T, Fischer E, Rock CS, Moldawer LL, Lowry SF. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc Nat Acad Sci USA 1992; 89: 4845-4849.
52. Porteu F, Nathan C. Shedding of tumor necrosis factor receptors by activated human neutrophils. J Exp Med 1990; 172: 599-607.
53. Kishimoto T, Hibi M, Murakami M, Narazaki M, Saito M, Taga T. The molecular biology of interleukin 6 and its receptor. Ciba Found Symp 1992; 167: 5-16; discussion 16-23.
54. Hibi M, Murakami M, Saito M, Hirano T, Taga T, Kishimoto T. Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell 1990; 63: 1149-1157.
55. Stoyan T, Michaelis U, Schooltink H, Van-Dam M, Rudolph R, Heinrich PC, Rose-John S. Recombinant soluble human interleukin-6 receptor. Expression in Escherichia coli, renaturation and purification. Eur J Biochem 1993; 216: 239-245.
56. Honda M, Yamamoto S, Cheng M, Yasukawa K, Suauki H, Saito T, Osugi Y, Tokunaga T, Kishimoto T. Human soluble IL-6 receptor: its detection and enhanced release by HIV infection. J Immunol 1992; 148: 2175-2180.
57. Taga T, Hibi M, Hirata Y, Yamasaki K, Yasukawa K, Matsuda T, Hirano T, Kishimoto T. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell 1989; 58: 573-581.
58. Gerhartz C, Dittrich E, Stoyan T, Rose-John S, Yasukawa K, Heinrich PC, Graeve L. Biosynthesis and half-life of the interleukin-6 receptor and its signal transducer gp130. Eur J Biochem 1994; 223: 265-274.
59. Saito T, Yasukawa K, Suzuki H, Futatsugi K, Fukunaga T, Yokomizo C, Koishihara Y, Fukui H, Ohsugi Y, Yawata H, Kobayashi I, Hirano T, Taga T, Kishimoto T. Preparation of soluble murine IL-6 receptor and anti-murine IL-6 receptor antibodies. J Immunol 1991; 147: 168-173.
60. Yasukawa K, Futatsugi K, Saito T, Yawata H, Narazaki M, Suzuki H, Taga T, Kishimoto T. Association of recombinant soluble IL-6-signal transducer, gp130, with a complex of IL 6 and soluble IL-6 receptor, and establishment of an ELISa for soluble gp130. Immunol Lett 1992; 31: 123-130.
61. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha-and obesity-induced insulin resistance. Science 1996; 271: 665-668.
62. Hotamisligil GS, Budavari A, Murray D, Spiegelman BM. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. J Clin Invest 1994; 94: 1543-1549.
63. Stephens JM, Lee J, Pilch PF. Tumor necrosis factor-α-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction. J Biol Chem 1997; 272: 971-976.
64. Guo D, Donner DB. Tumor necrosis factor promotes phosphorylation and binding of insulin receptor substrate 1 to phosphatodiylinositol 3-kinase in 3T3-L1 adipocytes. J Biol Chem 1996; 271: 615-618.
65. Sayeed MM. Alteractions in calcium signaling and cellular responses in septic injury. New Horiz 1996; 4: 72-86.
66. Berg M, Fraker DL, Alexander HR. Characterisation of differentiation factor/leukaemia inhibitory factor effect on lipoprotein lipase activity and mRNA in 3T3-L1 adipocytes. Cytokine 1884; 6: 425-432.
67. Greenberg AS, Nordon RP, McIntosh J, Calvo JC, Scow RO, Jablons D. Interleukin-6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: a possible role for interleukin-6 in cancer cachexia. Cancer Res 1992; 52: 4113-4116.
68. Matthys P, Billiau A. Cytokines and cachexia. Nutrition 1997; 13: 763-770.
69. Strassmann G, Fong M, Windsor S, Neta R. The role of interleukin-6 in lipopolysaccharide-induced weight loss, hypoglycemia and fibrinogen production, in vivo. Cytokine 1993; 5: 285-290.
70. Jones TH, Kennedy RL. Cytokines and hypothalamic pituitary function. Cytokine 1993; 5: 531-538.
71. Rothwell NJ. CNS regulation of thermogenesis. Crit Rev Neurobiol 1994; 8: 1-10.
72. Maslowska M, Scantlebury T, Germinario R, Cianflone K. Acute in vitro production of acylation stimulating protein in differentiated human adipocytes. J Lipid Res 1997; 38: 1-11.
73. Cianflone KM, Sniderman AD, Dallongeville J, Bertrand M, Raffai E, Davignon J. The relation between triglyceride synthesis in peripheral tissues and postprandial plasma triglyceride levels: preliminary evidence of a role for acylation stimulating protein. Clin Invest Med 1992; 15: 132-140.
74. Cianflone K, Roncari DA, Maslowska M, Baldo A, Forden J, Sniderman AD. Adipsin/acylation stimulating protein system in human adipocytes: regulation of triacylglycerol synthesis. Biochemistry 1994; 33: 9489-9495.
75. Germinario R, Sniderman AD, Manuel S, Lefebvre SP, Baldo A, Cianflone K. Coordinating regulation of triacylglycerol synthesis and glucose transport by acylation-stimulating protein. Metabolism 1993; 42: 574-580.
76. Baldo A, Sniderman AD, St-Luce S, Zhang XJ, Cianflone K. Signal transduction pathway of acylation stimulating protein: involvement of protein kinase C. J Lipid Res 1995;36:1415-1426.
77. Cianflone K. Obesity and the adipocyte: Acylation stimulating protein and the adipocyte. J Endocrinol 1997; 155: 203-206.
78. Coppack SW, Jensen MD, Miles JM. In vivo regulation of lipolysis in humans. J Lipid Res 1994; 35: 177-193.
79. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963; 1: 785-789.
80. Kissebah AH. Insulin resistance in visceral obesity. Int J Obes 1991; 15: 109-115.
81. Frayn KN, Coppack SW. Insulin resistance, adipose tissue and coronary heart disease. Clin Sci 1992; 82: 1-8.
82. Amri EZ, Teboul L, Vannier C, Grimaldi PA, Ailhaud G. Fatty acids regulate the expression of lipoprotein lipase gene and activity in preadipose and adipose cells. Biochem J 1996; 314: 541-546.
83. Wojtczak L, Schonfeld P. Effect of fatty acids on energy coupling processes in mitochondria. Biochim Biophy Acta 1993; 1183: 41-57.
84. Licinio J, Mantzoros C, Negrao AB, Cizza G, Wong ML, Bongiorno PB, Chrousos GP, Karp B, Allen C, Flier JS, Gold PW. Human leptin levels are pulsatile and inversely related to pituitary-adrenal function. Nat Med 1997; 3: 575-579.
85. Haffner SM, Miettinen H, Karhapaa P, Mykkanen L, Laakso M. Leptin concentrations, sex hormones, and cortisol in nondiabetic men. J Clin Endocrinol Metab 1997; 82: 1807-1809.
86. Bornstein SR, Uhlmann KI, Haidan A, Ehrhart-Bornstein M, Scherbaum WA. Evidence for a novel peripheral action of leptin as a metabolic signal to the adrenal gland: leptin inhibits cortisol release directly. Diabetes 1997; 46: 1235-1238.
87. Schwartz MW, Seeley RJ, Campfield LA, Burn P, Baskin DG. Identification of targets of leptin action in rat hypothalamus. J Clin Invest 1996; 98: 1101-1106.
88. Cizza G, Lotsikas A, Chrousos GP. Plasma leptin and cortisol levels in Cushing patients before and after correction of hypercortisolism and in lean controls. Endocrine Society 1997; (abstract).
89. Zakrzewska KE, Cusin I, Sainsbury A, Rohner-Jeanrenaud F, Jeanrenaud B. Glucocorticoids as counterregulatory hormones of leptin: toward an understanding of leptin resistance. Diabetes 1997; 46: 717-719.
90. Navarra P, Tsagarakis S, Faria MS, Rees LH, Besser GM, Grossman AB. Interleukins-1 and -6 stimulate the release of corticotropin-releasing hormone-41 from rat hypothalamus in vitro via the eicosanoid cyclooxygenase pathway. Endocrinology 1991; 128: 37-44.
91. Ebisui O, Fukata J, Murakami N, Kobayashi H, Segawa H, Muro S, Hanaoka I, Naito Y, Masui Y, Ohmoto Y, Imura H, Nakao K. Effect of IL-1 receptor antagonist and antiserum to TNF-α on LPS-induced plasma ACTH and corticosterone rise in rats. Am J Physiol 1994; 266: E986-E992.
92. Lyson K, McCann SM. Induction of adrenocorticotropic hormone release by interleukin-6 in vivo and in vitro. Ann NY Acad Sci 1992; 650: 182-185.
93. Kageyama K, Watanobe H, Takebe K. In vivo evidence that arginine vasopressin is involved in the adrenocorticotropin response induced by interleukin-6 but not by tumor necrosis factor-alpha in the rat. Neuroimmunomodulation 1995; 2: 137-140.
94. Shimon I, Yan X, Ray DW, Melmed S. Cytokine-dependent gp130 receptor subunit regulates human fetal pituitary adreno-corticotropin hormone and growth hormone secretion. J Clin Invest 1997; 100: 357-363.
95. Brattsand R, Linden M. Cytokine modulation by glucocorticoids: mechanisms and actions in cellular studies. Aliment Pharmacol Ther 1996; 10: 81-92.
96. Calogero AE, Burrello N, Negri-Cesi P, Papale L, Palumba MA, Cianci A, Sanfilippo S, D'Agata R. Effects of corticotropin-releasing hormone on ovarian estrogen production in vitro. Endocrinology 1996; 137: 4161-4166.
97. Nikolarakis KE, Almeida OF, Herz A. Hypothalamic opioid receptors mediate the inhibitory actions of corticotropin-releasing hormone on luteinizing hormone release: further evidence from a morphine-tolerant animal model. Brain Res 1998; 450: 360-363.
98. Tsigos C, Papanicolaou DA, Defensor R, Mitsiadis CS, Kyrou I, Chrousos GP. Dose effects of recombinant human interleukin-6 on pituitary hormone secretion and energy expenditure. Neuroimmunology 1997; 66: 54-62.
99. Rivier C, Vale W. Cytokines act within the brain to inhibit luteinizing hormone secretion and ovulation in the rat. Endocrinology 1990; 127: 849-856.
100. Lyson K, McCann SM. The effect of interleukin-6 on pituitary hormone release in vivo and in vitro. Neuroendocrinology 1991; 54: 262-266.
101. Kennedy JA, Wellby ML, Zotti R. Effect of interleukin-1 beta, tumour necrosis factor-alpha and interleukin-6 on the control of thyrotropin secretion. Life Sci 1995; 57: 487-501.
102. Spangelo BL, Judd AM, Isakson PC, MacLeod RM. Interleukin-6 stimulates anterior pituitary hormone release in vitro. Endocrinology 1989; 125: 575-577.
103. Ozawa M, Sato K, Han DC, Kawakami M, Tsushima T, Shizume K. Effects of tumor necrosis factor-α/cachectin on thyroid hormone metabolism in mice. Endocrinology 1988; 123: 1461-1467.
104. 125 organifiation and thyroid hormone release by interleukin-1, tumor necrosis factor-1, tumor necrosis factor-α and interferon-γ in human thyrocytes in suspension cultures. J Clin Endocrinol Metab 1990; 70: 1735-1743.
105. Trayhurn P, Duncan JS, Rayner DV, Hardie LJ. Rapid inhibition of ob gene expression and circulating leptin levels in lean mice by the beta 3-adrenoceptor agonists BRL 35135A and ZD2079. Biochem Biophys Res Commun 1996; 228: 605-610.
106. Trayhurn P, Duncan JS, Rayner DV. Acute cold-induced suppression of ob (obese) gene expression in white adipose tissue of mice: mediation by the sympathetic system. Biochem J 1995; 311: 729-731.
107. Donahoo WT, Jensen DR, Yost TJ, Eckel RH. Isoproterenol and somatostatin decrease plasma leptin in humans: a novel mechanism regulating leptin secretion. J Clin Endocrinol Metab 1997; 82: 4139-4143.
108. Pinkney JH, Coppack SW, Mohamed-Ali V. Effect of isoprenaline on plasma leptin and lipolysis in humans. Clin Endocrinol 1998; 48: 407-411.
109. Sreenan S, Caro JF, Refetoff S. Thyroid dysfunction is not associated with alterations in serum leptin levels. Thyroid 1997; 7: 407-409.
110. Valcavi R, Zini M, Peino R, Casaneuva FF, Dieguez C. Influence of thyroid hormone on serum immunoreactive leptin levels. J Clin Endocrinol Metab 1997; 82: 1632-1634.
111. Yoshida T, Monkawa T, Hayashi M, Saruta T. Regulation of expression of leptin mRNA and secretion of leptin by thyroid hormone in 3T3-L1 adipocytes. Biochem Biophvs Res Commun 1997; 232: 822-826.
112. Bruysek L, Houstek J. Beta-adrenergic stimulation of interleukin-1 alpha and interleukin-6 expression in mouse brown adipocytes. FEBS Lett 1997; 411: 83-86.
113. Papanicolaou DA, Petrides JS, Tsigos C, Bina S, Kalogeras KT, Wilder R, Gold PW, Deuster PA, Chrousos GP. Exercise stimulates interleukin-6 secretion: inhibition by glucocorticoids and correlation with catecholamines. Am J Physiol 1996; 271: E601-E605.
114. van-der-Poll T, Jansen J, Endert E, Sauerwein HP, van-Deventer SJ. Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin-6 production in human whole blood. Inject Immun 1994; 62: 2046-2050.
115. Morohoshi M, Fujisawa K, Uchimura I, Numano F. Glucose-dependent interleukin 6 and tumor necrosis factor production by human peripheral blood monocytes in vitro. Diabetes 1996; 45: 954-959.
116. Morohoshi M, Fujisawa K, Uchimura I, Numano F. The effect of glucose and advanced glycosylation end products on IL-6 production by human monocytes. Ann N Y Acad Sci 1995; 748: 562-570.
117. Ghilardi N, Skoda RC. The leptin receptor activates janus kinase 2 and signals for proliferation in a factor-dependent cell line. Mol Endocrinol 1997; 11: 393-399.
118. White DW, Tartaglia LA. Leptin and OB-R: body weight regulation by a cytokine receptor. Cytokine Growth Factor Rev 1996; 7: 303-309.
119. Grunfeld C, Zhao C, Fuller J, Pollack A, Moser A, Friedman J, Feingold KR. Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. J Clin Invest 1996; 97: 2152-2157.
120. Kohase M, Henriksen-DeStefano D, May LT, Vilcek J, Sehgal PB. Induction of beta 2-interferon by tumor necrosis factor: a homeostatic mechanism in the control of cell proliferation. Cell 1986; 45: 659-666.
121. Kirchgessner TG, Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. Tumor necrosis factor-alpha contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes. J Clin Invest 1997; 100: 2777-2782.
122. Labrie F, Simard J, Luu-The V, Trudel C, Martel C, Labrie C, Zhao HF, Rheaume E, Couet J, Breton N. Expression of 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase (3 beta-HSD) and 17 beta-hydroxysteroid dehydrogenase (17 beta-HSD) in adipose tissue. Int J Obes 1991; 15: 91-99.
123. Simpson ER, Zhao Y, Agarwal VR, Michael MD, Bulun SE, Hinshelwood MM, Graham-Lorence S, Sun T, Fisher CR, Qin K, Mendelson CR. Aromatase expression in health and disease. Recent progress in Hormone Research 1997; 52: 185-213.
124. Pedersen SB, Fuglsig S, Sjogren P, Richelsen B. Identification of steroid receptors in human adipose tissue. Eur J Clin Invest 1996; 26: 1051-1056.
125. Björntorp P. Endocrine abnormalities of obesity. Metabolism: Clin Exp 1995; 44: 21-23.
126. Rigden DJ, Jellyman AE, Frayn KN, Coppack SW. Human adipose tissue glycogen levels and responses to carbohydrate feeding. Eur J Clin Nutr 1990; 44: 689-692.
127. Arroyo A, Laughlin GA, Morales AJ, Yen SS. Inappropriate gonadotrophin secretion in polycystic ovary syndrome: influence of adiposity. J Clin Endocrinol Metab 1997; 82: 3728-3733.
128. Azziz R. Reproductive endocrinologic alterations in female asymptomatic obesity. Fertil Steril 1989; 52: 703-725.
129. Svendsen OL, Hassager C, Christiansen C. Relationships and independence of body composition, sex hormones, fat distribution and other cardiovascular risk factors in overweight postmenopausal women. Int J Obes 1993; 17: 459-463.
130. Leenen R, van der Kooy K, Seidell JC, Deurenberg P, Koppeschaar HP. Visceral fat accumulation in relation to sex hormones in obese men and women undergoing weight loss therapy. J Clin Endocrinol Metab 1994; 78: 1515-1520.
131. Tehernof A, Despres JP, Belanger A, Dupont A, Prud'homme D, Moorjani S, Lupien PJ, Labrie F. Reduced testosterone and adrenal C19 steroid levels in obese men. Metab: Clin Exp 1995; 44: 513-519.
132. Björntorp P. The regulation of adipose tissue distribution in humans. Int J Obes 1996; 20: 291-302.
133. Yang K, Khalil MW, Strutt BJ, Killiger DW. 11 Betahydroxy-steroid dehydrogenase 1 activity and gene expression in human adipose stromal cells: effect on aromatase activity. J Steroid Biochem Mol Biol 1997; 60: 247-253.
134. Bujalska IJ, Kumar S, Stewart PM. Does obesity reflect "Cushing's disease of the omentum"? Lancet 1997; 349: 1210-1213.
135. Eckel RH. Insulin resistance: an adaptation for weight maintainance. Lancet 1992; 340: 1452-1453.
136. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
137. Summers LKM, Samra JS, Humphreys SM, Morris RJ, Frayn KN. Subcutaneous abdominal adipose tissue blood flow: variation within and between subjects and relationship to obesity. Clin Sci 1996; 91: 679-683.
138. Sjöström L. The Metabolic Syndrome of Human Obesity. In: Bouchard C, Bray GA (eds). Regulation of Body Weight Biological and Behavioural Mechanisms. Wiley & Sons, Chichester, 1996.
139. van der Kooy K, Seidell JC. Techniques for the measurement of visceral fat: a practical guide. Int J Obes 1993; 17: 187-196.
140. Jensen MD, Kanaley JA, Roust LR, O'Brien PC, Braun JS, Dunn WL, Wahner HW. Assessment of body composition with use of dual-energy X-ray absorptiometry: evaluation and comparison with other methods. Mayo Clinic Proc 1993; 68: 867-873.
141. Seidell JC, Bouchard C. Visceral fat in relation to health: is it a major culprit or simply an innocent bystander? Int J Obes 1997; 21: 626-631.
142. Brunner E, Juneja M, Marmot MG. Abdominal obesity and disease are linked to social position. Br Med J 1998; 316: 308-309.
143. Montague CT, Prins JB, Sanders L, Digby JF, O'Rahilly S. Depot-and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution. Diabetes 1997; 46: 342-347.
144. Rebuffe-Scrive M, Lundholm K, Bjorntorp P. Glucocorticoid hormone binding to human adipose tissue. Eur J Clin Invest 1985; 15: 267-271.
145. Hauner H, Entenmann G. Regional variation of adipose differentiation in cultured stromalvascular cells from abdominal and femoral adipose tissue of obese women. Int J Obesity 1991; 15: 121-126.
146. Martin ML, Jensen MD. Effects of body fat distribution on regional lipolysis in obesity. J Clin Invest 1991; 88: 609-613.
147. Peiris AN, Mueller RA, Struve GA, Kissebah AH. Relation of androgenic activity to splanchnic insulin metabolism and peripheral glucose utilisation in premenopausal women. J Clin Endocrinol Metab 1987; 64: 162-169.
148. Bostrom K, Boren J, Wettesten M, Sjoberg A, Bondjers G, Wiklund O, Carlsson P, Olofsson SO. Studies on the assembly of apo-B 100 containing lipoproteins in Hep G2 cells. J Biol Chem 1988; 263: 4424-4442.
149. Hauner H. Obesity and the adipocyte: obesity and diabetes -potential for intervention. J Endocrinol 1997; 155: 223.
150. Reynisdottir S, Wahrenberg H, Carlstrom K, Rossner S, Arner P. Catecholamine resistance in fat cells of women with upper body obesity due to decreased expression of beta 2-adrenoceptors. Diabetologia 1995; 38: 126-128.
151. Bougneres P, Le-stunff C, Pecqueur C, Pinglier E, Adnot P, Ricquier D. In vivo resistance of lipolysis to epinephrine. A new feature of childhood onset obesity. J Clin Invest 1997; 99: 2568-2573.
152. Ramirez ME, McMurry MP, Wiebke GA, Felten KJ, Ren K, Meikle AW, Iverius PH. Evidence for sex steroid inhibition of lipoprotein lipase in men: comparison of abdominal and femoral adipose tissue. Metabolism 1997; 46: 179-185.